Oxford Cancer Biomarkers is an Oxford-based biomarker company commercializing biomarker tests for colorectal cancer testing.
Oxford Cancer Biomarkers was created by University of Oxford cancer professors, Nick La ThangueNick La Thangue and David Kerr to transform personalised medicine using biomarker technology. Its current tests focus on colorectal cancer diagnosis, management and treatment, and it aims to expand its portfolio of tests to serve as benefit for other cancer treatment programmes.